KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Short-term Investments (2016 - 2025)

Rigel Pharmaceuticals has reported Short-term Investments over the past 16 years, most recently at $114.4 million for Q4 2025.

  • For Q4 2025, Short-term Investments rose 455.89% year-over-year to $114.4 million; the TTM value through Dec 2025 reached $114.4 million, up 455.89%, while the annual FY2025 figure was $114.4 million, 455.89% up from the prior year.
  • Short-term Investments for Q4 2025 was $114.4 million at Rigel Pharmaceuticals, up from $88.6 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $114.4 million in Q4 2025 and troughed at $9.4 million in Q3 2024.
  • A 5-year average of $48.4 million and a median of $32.6 million in 2022 define the central range for Short-term Investments.
  • Biggest five-year swings in Short-term Investments: tumbled 77.82% in 2023 and later skyrocketed 840.45% in 2025.
  • Year by year, Short-term Investments stood at $106.1 million in 2021, then tumbled by 68.19% to $33.7 million in 2022, then decreased by 28.45% to $24.1 million in 2023, then decreased by 14.79% to $20.6 million in 2024, then skyrocketed by 455.89% to $114.4 million in 2025.
  • Business Quant data shows Short-term Investments for RIGL at $114.4 million in Q4 2025, $88.6 million in Q3 2025, and $55.0 million in Q2 2025.